Hematology TimesFDA approves biosimilar filgrastimJuly 22, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationAMLALL
Hematology TimesNew approach to AE reporting needed, group saysJuly 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Hematology TimesTransplant strategy not viable for aggressive B-NHLJuly 6, 2018Lymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology Times‘Excellent’ survival with HCT despite early treatment failure in FLJune 16, 2018Lymphoma & Plasma Cell DisordersTransplantationAggressive LymphomasFollicular Lymphoma
Hematology TimesDasatinib outcomes similar to imatinib in pediatric Ph+ ALLJune 9, 2018Leukemia, Myelodysplasia, TransplantationPediatricsTransplantationALL
Hematology TimesOlder, cheaper drug formulation to remain availableMay 21, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCAR T-cell therapy bridges to HSCT in AML patientMay 9, 2018Leukemia, Myelodysplasia, TransplantationTransplantationAML
